1. Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified release products: workshop summary report;Chen;Eur. J. Pharm. Sci.,2010
2. European Agency for the Evaluation of Medicinal Products, Committee for Medicinal Products for Human Use (CPMP), 1995. Note for Guideline on the Clinical Requirements for Locally Applied, Locally Acting Products Containing Known Constituents. London. (accessed 6.4.11).
3. European Agency for the Evaluation of Medicinal Products, Committee for Medicinal Products for Human Use (CPMP), 1999. Note for Guidance on Modified Release Oral and Transdermal Dosage Forms: Section II (Pharmacokinetic and Clinical Evaluation). London. (accessed 27.4.11).
4. European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), 2010. Guideline on the Investigation of Bioequivalence. London. (accessed 20.4.11).
5. Gillespie, W.R., 1996. Bioequivalence assessment based on pharmacodynamic response – bioequivalence on the dose scale: rationale, theory and methods. Presentation to a joint session of the Advisory Committee for Pharmaceutical Science and Pulmonary-Allergy Drugs Advisory Committee, Gaithersburg, Maryland, October 16, Transcript, pp. 40–52.